CAD 0.14
(3.85%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - |
Cost of Revenue | 13.67 Thousand | 12.12 Thousand | 13.38 Thousand | 390.00 | 112.00 | 151.20 |
Gross Profit | -13.67 Thousand | -12.12 Thousand | -13.38 Thousand | -390.00 | -112.00 | -151.20 |
Operating Expenses | 5.96 Million | 7.11 Million | 5.37 Million | 3.95 Million | 2.55 Million | 1.75 Million |
Selling, General and Administrative Expenses | 5.96 Million | 1.92 Million | 2.33 Million | 2.01 Million | 1.39 Million | 1.75 Million |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | - | - | 3.04 Million | 1.94 Million | 1.16 Million | - |
Cost and Expenses | 5.96 Million | 7.12 Million | 5.39 Million | 3.95 Million | 2.55 Million | 1.75 Million |
Operating Income | -5.96 Million | -7.23 Million | -5.38 Million | -3.93 Million | -2.49 Million | -1.75 Million |
Interest Expense | 130.42 Thousand | - | 5352.00 | - | - | - |
Income Tax Expense | -112.61 Thousand | -114.04 Thousand | 5352.00 | 25.61 Thousand | 100.29 Thousand | -1.20 |
Earnings before Tax | -6.11 Million | -7 Million | -5.39 Million | -3.92 Million | -2.59 Million | -2.93 Million |
Net Income | -6 Million | -7 Million | -5.4 Million | -3.95 Million | -2.69 Million | -2.93 Million |
Earnings Per Share Basic | -0.05 | -0.07 | -0.06 | -0.06 | -0.07 | -0.12 |
Earnings Per Share Diluted | -0.05 | -0.07 | -0.06 | -0.06 | -0.07 | -0.12 |
Weighted Average Shares Outstanding | 114.97 Million | 104.52 Million | 88.4 Million | 65.2 Million | 39.89 Million | 24.43 Million |
Weighted Average Shares Outstanding (Diluted) | 114.97 Million | 104.52 Million | 88.4 Million | 65.2 Million | 39.89 Million | 24.43 Million |
Gross Margin | - | - | - | - | - | - |
EBIT Margin | - | - | - | - | - | - |
Profit Margin | - | - | - | - | - | - |
EBITDA | -5.96 Million | -7.05 Million | -5.38 Million | -3.92 Million | -2.59 Million | -1.75 Million |
Earnings Before Tax Margin | - | - | - | - | - | - |
Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - |
Cost of Revenue | 5854.00 | 13.67 Thousand | 4538.00 | 3501.00 | 2019.00 | 3617.00 |
Gross Profit | -5854.00 | -13.67 Thousand | -4538.00 | -3501.00 | -2019.00 | -3617.00 |
Operating Expenses | 901.98 Thousand | 6.02 Million | 778.01 Thousand | 3.91 Million | 718.36 Thousand | 612.39 Thousand |
Selling, General and Administrative Expenses | 591.97 Thousand | - | 778.01 Thousand | 3.91 Million | 399.89 Thousand | 612.39 Thousand |
Research and Development Expenses | - | - | - | - | - | - |
Other Expenses | 310 Thousand | - | - | - | - | - |
Cost and Expenses | 907.84 Thousand | 6.03 Million | 782.55 Thousand | 3.91 Million | 720.37 Thousand | 616 Thousand |
Operating Income | -896.94 Thousand | -6.03 Million | -782.55 Thousand | -3.91 Million | -724.74 Thousand | -616.01 Thousand |
Interest Expense | 191.89 Thousand | 130.42 Thousand | 130.42 Thousand | - | - | - |
Income Tax Expense | -58.28 Thousand | -112.61 Thousand | -112.61 Thousand | -1.00 | -6382.00 | 3.00 |
Earnings before Tax | -1.09 Million | -6.11 Million | -911.13 Thousand | -3.87 Million | -716.01 Thousand | -621.52 Thousand |
Net Income | -1.03 Million | -6 Million | -798.52 Thousand | -3.87 Million | -716.01 Thousand | -621.52 Thousand |
Earnings Per Share Basic | -0.01 | - | -0.01 | -0.03 | -0.01 | -0.01 |
Earnings Per Share Diluted | -0.01 | - | -0.01 | -0.03 | -0.01 | -0.01 |
Weighted Average Shares Outstanding | 130.87 Million | 114.97 Million | 129.4 Million | 112.31 Million | 111.53 Million | 107.06 Million |
Weighted Average Shares Outstanding (Diluted) | 130.87 Million | 114.97 Million | 129.4 Million | 112.31 Million | 111.53 Million | 107.06 Million |
Gross Margin | - | - | - | - | - | - |
EBIT Margin | - | - | - | - | - | - |
Profit Margin | - | - | - | - | - | - |
EBITDA | -891.08 Thousand | - | -778.01 Thousand | -3.91 Million | -724.74 Thousand | -612.39 Thousand |
Earnings Before Tax Margin | - | - | - | - | - | - |
IPGGF
CLRMF
IAUFF
SAGA-B
BYLOF
TROAX